| For: | Yin X, He XK, Wu LY, Yan SX. Effect of prior malignancy on the prognosis of gastric cancer and somatic mutation. World J Clin Cases 2022; 10(5): 1485-1497 [PMID: 35211586 DOI: 10.12998/wjcc.v10.i5.1485] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v10/i5/1485.htm |
| Number | Citing Articles |
| 1 |
Hannah C. Puhr, Luzia Berchtold, Linda Zingerle, Martin Korpan, Julia M. Berger, Gerd Jomrich, Reza Asari, Sebastian F. Schoppmann, Gerald W. Prager, Elisabeth S. Bergen, Anna S. Berghoff, Matthias Preusser, Aysegül Ilhan-Mutlu. Lack of association between prior or concurrent malignancies and overall survival in gastroesophageal cancer: evidence from a large European single-center cohort. Clinical and Translational Oncology 2025; 28(3): 942 doi: 10.1007/s12094-025-04036-3
|
| 2 |
Seiji Hoshi, Kouji Izumi, Satoru Meguro, Takashi Shima, Yuki Kato, Koji Mita, Takehiko Okamura, Shogo Inoue, Shuichi Tatarano, Nobumichi Tanaka, Yuko Yoshio, Manabu Kamiyama, Ippei Chikazawa, Noriyasu Kawai, Kohei Hashimoto, Takashi Fukagai, Kazuyoshi Shigehara, Shizuko Takahara, Atsushi Mizokami. Efficacy and Safety of Enzalutamide and Abiraterone in CRPC Patients With a History of Other Cancers: A Sub‐Analysis of the ENABLE Study for PCa. International Journal of Urology 2026; 33(5) doi: 10.1111/iju.70511
|